Lung Cancer Treatment Market - By Type (Carcinoid, Non-small & Small Cell), By Therapy [(Radiation, Immunotherapy (Durvalumab), Targeted (Bevacizumab), Chemotherapy], By End-user (Hospitals, Specialty Clinics, Homecare), Global Forecast, 2023-2032

Lung Cancer Treatment Market - By Type (Carcinoid, Non-small & Small Cell), By Therapy [(Radiation, Immunotherapy (Durvalumab), Targeted (Bevacizumab), Chemotherapy], By End-user (Hospitals, Specialty Clinics, Homecare), Global Forecast, 2023-2032


Global Lung Cancer Treatment Market size will grow substantially during 2023-2032. Rising air pollution levels due to accelerating urbanization and industrial growth worldwide have resulted in increased incidences of lung cancer, bolstering the need for its treatment. As per the WHO, ambient air pollution is projected to lead to 16% of lung cancer deaths, while air pollution may be responsible for around 29% of the deaths caused by lung cancer globally. The increasing disease burden has bolstered awareness about its early diagnosis and treatment to prevent further complications, contributing to market growth.

The overall lung cancer treatment market is segmented based on type, therapy, end-user, and region.

Based on type, the market share from the carcinoid segment will depict significant growth through 2032. Growing prevalence of lung cancer and high mortality rate associated with it has increased the need for its treatment. According to the American Cancer Society, the U.S. reports around 2,000 to 4,500 lung carcinoid tumors every year. Moreover, improved diagnostic techniques and the rising awareness of carcinoid tumors have propelled the number of patients undergoing treatment of this condition, thus, adding to market revenue.

In terms of therapy, the lung cancer treatment market value from the chemotherapy segment will accrue significant gains through 2032. Advances in genomics and molecular profiling have enabled personalized medicine in chemotherapy. By analyzing a patient's tumor at a molecular level, doctors can identify specific genetic mutations or biomarkers that drive the cancer's growth. This information helps tailor the chemotherapy regimen to target those specific abnormalities, increasing treatment effectiveness.

Based on end-user, the lung cancer treatment market from the specialty clinics segment will observe appreciable growth over 2023-2032. High availability of cutting-edge diagnostic equipment has made specialty clinics a preferred healthcare provider. Additionally, these facilities are well-positioned to provide personalized care tailored to specific patient needs. They offer comprehensive evaluations, molecular profiling, and access to clinical trials, ensuring that patients receive the most appropriate and effective treatment options.

Regionally, Europe lung cancer treatment industry will grow at a decent CAGR from 2023 to 2032. High incidence rate of lung cancer has increased the need for its treatment in the region. Moreover, a strong presence of industry contenders such as Boehringer Ingelheim International GmbH, Merck KGaA, and others constantly focusing on developing advanced treatment options for lung cancer is positively impacting the regional market growth. Additionally, the rapid expansion of the existing healthcare infrastructure in the region will stimulate industry revenue streams through 2032.


Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market definitions
1.3 Base estimates and calculations
1.4 Forecast calculations
1.5 Data sources
1.6 Data validation
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Lung Cancer Treatment industry 360 degree synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Type trends
2.1.3 By Therapy trends
2.1.4 End-user trends
2.1.5 Regional trends
Chapter 3 Lung Cancer Treatment Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of lung cancer across the globe
3.2.1.2 The growing trend of smoking tobacco
3.2.1.3 Rising levels of air pollution due to rapid industrialization
3.2.1.4 Increasing emphasis on early diagnosis of cancers
3.2.1.5 Rising technological advancements in lung cancer treatment
3.2.1.6 Availability of reimbursement for lung cancer treatment
3.2.2 Industry pitfalls & challenges
3.2.2.1 The high cost of lung cancer treatments
3.2.2.2 Side effects of drugs and therapies
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By therapy
3.3.3 By end-user
3.4 COVID-19 impact analysis
3.5 Clinical trial analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Technology landscape
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Competitive dashboard, 2022
4.3 Company matrix analysis, 2022
4.4 Company market share analysis, 2022
4.5 Competitive positioning matrix, 2022
4.6 Strategic outlook matrix, 2022
Chapter 5 Lung Cancer Treatment Market Estimates and Forecast, By Type (USD Million)
5.1 Key trends, by type
5.2 Non-small cell lung cancer
5.3 Small cell lung cancer
5.4 Carcinoid
Chapter 6 Lung Cancer Treatment Market Estimates and Forecast, By Therapy (USD Million)
6.1 Key trends, by therapy
6.2 Radiation therapy
6.3 Immunotherapy
6.4 Targeted therapy
6.5 Chemotherapy
6.6 Other therapies
Chapter 7 Lung Cancer Treatment Market Estimates and Forecast, By End-user (USD Million)
7.1 Key trends, by end-user
7.2 Hospitals
7.3 Specialty clinics
7.4 Homecare
7.5 Other end-users
Chapter 8 Lung Cancer Treatment Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Merck KGaA
9.2 ONO PHARMACEUTICAL CO., LTD.
9.3 Boehringer Ingelheim International GmbH
9.4 GlaxoSmithKline plc.
9.5 Pfizer Inc.
9.6 Johnson & Johnson Services, Inc.
9.7 AstraZeneca
9.8 Takeda Pharmaceutical Company Limited
9.9 Church & Dwight Co., Inc.
9.10 Sun Pharmaceutical Industries Ltd.Takara Bio Inc.
Data Tables
TABLE 1. Product mapping
TABLE 2. Market revenue, by type (2022)
TABLE 3. Market revenue, by therapy (2022)
TABLE 4. Market share, by end-user (2022)
TABLE 5. Market share, by region (2022)
TABLE 6. Global lung cancer treatment market size, by region, 2018 - 2022 (USD Million)
TABLE 7. Global lung cancer treatment market size, by region, 2023 - 2032 (USD Million)
TABLE 8. Global lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 9. Global lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 10. Global lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 11. Global lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 12. Global lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 13. Global lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 14. Industry impact forces
TABLE 15. Non-small cell lung cancer market size, 2018 - 2022 (USD Million)
TABLE 16. Non-small cell lung cancer market size, 2023 - 2032 (USD Million)
TABLE 17. Small cell lung cancer market size, 2018 - 2022 (USD Million)
TABLE 18. Small cell lung cancer market size, 2023 - 2032 (USD Million)
TABLE 19. Carcinoid size, 2018 - 2022 (USD Million)
TABLE 20. Carcinoid size, 2023 - 2032 (USD Million)
TABLE 21. Radiation therapy, market size, 2018 - 2022 (USD Million)
TABLE 22. Radiation therapy, market size, 2023 - 2032 (USD Million)
TABLE 23. External beam radiation therapy market size, 2018 - 2022 (USD Million)
TABLE 24. External beam radiation therapy market size, 2023 - 2032 (USD Million)
TABLE 25. Internal beam radiation therapy market size, 2018 - 2022 (USD Million)
TABLE 26. Internal beam radiation therapy market size, 2023 - 2032 (USD Million)
TABLE 27. Systemic radiation therapy market size, 2018 - 2022 (USD Million)
TABLE 28. Systemic radiation therapy market size, 2023 - 2032 (USD Million)
TABLE 29. Immunotherapy therapy market size, 2018 - 2022 (USD Million)
TABLE 30. Immunotherapy therapy market size, 2023 - 2032 (USD Million)
TABLE 31. Durvalumab market size, 2018 - 2022 (USD Million)
TABLE 32. Durvalumab market size, 2023 - 2032 (USD Million)
TABLE 33. Nivolumab market size, 2018 - 2022 (USD Million)
TABLE 34. Nivolumab market size, 2023 - 2032 (USD Million)
TABLE 35. Atezolizumab market size, 2018 - 2022 (USD Million)
TABLE 36. Atezolizumab market size, 2023 - 2032 (USD Million)
TABLE 37. Pembrolizumab market size, 2018 - 2022 (USD Million)
TABLE 38. Pembrolizumab market size, 2023 - 2032 (USD Million)
TABLE 39. Other immunotherapies market size, 2018 - 2022 (USD Million)
TABLE 40. Other immunotherapies market size, 2023 - 2032 (USD Million)
TABLE 41. Targeted therapy market size, 2018 - 2022 (USD Million)
TABLE 42. Targeted therapy market size, 2023 - 2032 (USD Million)
TABLE 43. Bevacizumab market size, 2018 - 2022 (USD Million)
TABLE 44. Bevacizumab market size, 2023 - 2032 (USD Million)
TABLE 45. Dabrafenib/Trametinib market size, 2018 - 2022 (USD Million)
TABLE 46. Dabrafenib/Trametinib market size, 2023 - 2032 (USD Million)
TABLE 47. Erlotinib hydrochloride market size, 2018 - 2022 (USD Million)
TABLE 48. Erlotinib hydrochloride market size, 2023 - 2032 (USD Million)
TABLE 49. Osimertinib market size, 2018 - 2022 (USD Million)
TABLE 50. Osimertinib market size, 2023 - 2032 (USD Million)
TABLE 51. Other targeted therapies market size, 2018 - 2022 (USD Million)
TABLE 52. Other targeted therapies market size, 2023 - 2032 (USD Million)
TABLE 53. Chemotherapy market size, 2018 - 2022 (USD Million)
TABLE 54. Chemotherapy market size, 2023 - 2032 (USD Million)
TABLE 55. Other therapies market size, 2018 - 2022 (USD Million)
TABLE 56. Other therapies market size, 2023 - 2032 (USD Million)
TABLE 57. Hospitals market size, 2018 - 2022 (USD Million)
TABLE 58. Hospitals market size, 2023 - 2032 (USD Million)
TABLE 59. Specialty clinics market size, 2018 - 2022 (USD Million)
TABLE 60. Specialty clinics market size, 2023 - 2032 (USD Million)
TABLE 61. Homecare market size, 2018 - 2022 (USD Million)
TABLE 62. Homecare market size, 2023 - 2032 (USD Million)
TABLE 63. Other end-users market size, 2018 - 2022 (USD Million)
TABLE 64. Other end-users market size, 2023 - 2032 (USD Million)
TABLE 65. North America lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 66. North America lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 67. North America lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 68. North America lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 69. North America lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 70. North America lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 71. North America lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 72. North America lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 73. North America lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 74. North America lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 75. North America lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 76. North America lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 77. North America lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 78. North America lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 79. U.S. lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 80. U.S. lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 81. U.S. lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 82. U.S. lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 83. U.S. lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 84. U.S. lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 85. U.S. lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 86. U.S. lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 87. U.S. lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 88. U.S. lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 89. U.S. lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 90. U.S. lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 91. Canada lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 92. Canada lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 93. Canada lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 94. Canada lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 95. Canada lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 96. Canada lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 97. Canada lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 98. Canada lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 99. Canada lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 100. Canada lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 101. Canada lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 102. Canada lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 103. Europe lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 104. Europe lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 105. Europe lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 106. Europe lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 107. Europe lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 108. Europe lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 109. Europe lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 110. Europe lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 111. Europe lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 112. Europe lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 113. Europe lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 114. Europe lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 115. Europe lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 116. Europe lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 117. Germany lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 118. Germany lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 119. Germany lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 120. Germany lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 121. Germany lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 122. Germany lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 123. Germany lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 124. Germany lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 125. Germany lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 126. Germany lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 127. Germany lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 128. Germany lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 129. UK lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 130. UK lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 131. UK lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 132. UK lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 133. UK lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 134. UK lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 135. UK lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 136. UK lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 137. UK lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 138. UK lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 139. UK lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 140. UK lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 141. France lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 142. France lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 143. France lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 144. France lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 145. France lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 146. France lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 147. France lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 148. France lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 149. France lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 150. France lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 151. France lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 152. France lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 153. Italy lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 154. Italy lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 155. Italy lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 156. Italy lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 157. Italy lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 158. Italy lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 159. Italy lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 160. Italy lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 161. Italy lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 162. Italy lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 163. Italy lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 164. Italy lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 165. Spain lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 166. Spain lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 167. Spain lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 168. Spain lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 169. Spain lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 170. Spain lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 171. Spain lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 172. Spain lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 173. Spain lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 174. Spain lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 175. Spain lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 176. Spain lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 177. Rest of Europe lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 178. Rest of Europe lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 179. Rest of Europe lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 180. Rest of Europe lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 181. Rest of Europe lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 182. Rest of Europe lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 183. Rest of Europe lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 184. Rest of Europe lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 185. Rest of Europe lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 186. Rest of Europe lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 187. Rest of Europe lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 188. Rest of Europe lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 189. Asia Pacific lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 190. Asia Pacific lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 191. Asia Pacific lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 192. Asia Pacific lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 193. Asia Pacific lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 194. Asia Pacific lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 195. Asia Pacific lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 196. Asia Pacific lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 197. Asia Pacific lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 198. Asia Pacific lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 199. Asia Pacific lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 200. Asia Pacific lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 201. Asia Pacific lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 202. Asia Pacific lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 203. China lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 204. China lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 205. China lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 206. China lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 207. China lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 208. China lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 209. China lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 210. China lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 211. China lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 212. China lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 213. China lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 214. China lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 215. Japan lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 216. Japan lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 217. Japan lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 218. Japan lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 219. Japan lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 220. Japan lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 221. Japan lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 222. Japan lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 223. Japan lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 224. Japan lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 225. Japan lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 226. Japan lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 227. India lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 228. India lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 229. India lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 230. India lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 231. India lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 232. India lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 233. India lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 234. India lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 235. India lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 236. India lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 237. India lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 238. India lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 239. Australia lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 240. Australia lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 241. Australia lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 242. Australia lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 243. Australia lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 244. Australia lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 245. Australia lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 246. Australia lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 247. Australia lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 248. Australia lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 249. Australia lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 250. Australia lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings